1 recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 1, Withdrawn 1 |
Follow Morning Sickness: new trials by email Literature Review of Morning Sickness trials Research Report on Morning Sickness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperemesis Gravidarum Risk Reduction With Metformin Metformin Extended Release Oral Tablet - Hyperemesis Gravidarum | Phase 1 / Phase 2 | Recruiting | University of Southern California | 224 | 2026-07-13 | 2026-07-22 |
| Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP) Mirtazapine - Pregnancy, Severe Nausea and Vomiting | Phase 1 / Phase 2 | Withdrawn | Northwestern University | 2022-06-13 | 2024-12-11 |
Hyperemesis Gravidarum (2) · Nausea (2) · Vomiting (2)
Female Urogenital Diseases and Pregnancy Complications (2) · Pathological Conditions, Signs and Symptoms (2) · Pregnancy Complications (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Urogenital Diseases (2)
Mirtazapine (1)
Northwestern University (1) · University of Southern California (1)
United States (2)
Katherine L Wisner, M.D., M.S. (1) · Marlena Fejzo, PhD (1)
R21HD105101 (1)